ES2104736T3 - Esteroides con puente de 2beta,19-metileno-amino utilizados como inhibidores de aromatasa. - Google Patents

Esteroides con puente de 2beta,19-metileno-amino utilizados como inhibidores de aromatasa.

Info

Publication number
ES2104736T3
ES2104736T3 ES91920606T ES91920606T ES2104736T3 ES 2104736 T3 ES2104736 T3 ES 2104736T3 ES 91920606 T ES91920606 T ES 91920606T ES 91920606 T ES91920606 T ES 91920606T ES 2104736 T3 ES2104736 T3 ES 2104736T3
Authority
ES
Spain
Prior art keywords
aromatase inhibitors
2beta
methylene
amino used
steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91920606T
Other languages
English (en)
Spanish (es)
Inventor
J O'neal Johnston
Norton P Peet
Joseph P Burkhart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2104736T3 publication Critical patent/ES2104736T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES91920606T 1990-11-30 1991-10-17 Esteroides con puente de 2beta,19-metileno-amino utilizados como inhibidores de aromatasa. Expired - Lifetime ES2104736T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/621,183 US5126488A (en) 1990-11-30 1990-11-30 2β,19-methyleneamino bridged steroids as aromatase inhibitors

Publications (1)

Publication Number Publication Date
ES2104736T3 true ES2104736T3 (es) 1997-10-16

Family

ID=24489088

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91920606T Expired - Lifetime ES2104736T3 (es) 1990-11-30 1991-10-17 Esteroides con puente de 2beta,19-metileno-amino utilizados como inhibidores de aromatasa.

Country Status (15)

Country Link
US (1) US5126488A (enExample)
EP (1) EP0559706B1 (enExample)
JP (1) JP3021651B2 (enExample)
KR (1) KR100200462B1 (enExample)
AT (1) ATE154606T1 (enExample)
AU (1) AU647226B2 (enExample)
CA (1) CA2096020C (enExample)
DE (1) DE69126622T2 (enExample)
DK (1) DK0559706T3 (enExample)
ES (1) ES2104736T3 (enExample)
FI (1) FI932446A7 (enExample)
GR (1) GR3024298T3 (enExample)
HU (1) HU213608B (enExample)
NO (1) NO302123B1 (enExample)
WO (1) WO1992009619A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510340A (en) * 1992-06-12 1996-04-23 Sri International Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
AU630008B2 (en) * 1989-12-20 1992-10-15 Merrell Dow Pharmaceuticals Inc. 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors

Also Published As

Publication number Publication date
FI932446A0 (fi) 1993-05-28
HUT64365A (en) 1993-12-28
HU213608B (en) 1997-08-28
WO1992009619A1 (en) 1992-06-11
EP0559706B1 (en) 1997-06-18
JPH06509543A (ja) 1994-10-27
NO931951D0 (no) 1993-05-28
DE69126622T2 (de) 1997-10-23
US5126488A (en) 1992-06-30
CA2096020A1 (en) 1992-05-31
DK0559706T3 (da) 1997-09-08
JP3021651B2 (ja) 2000-03-15
FI932446L (fi) 1993-05-28
DE69126622D1 (de) 1997-07-24
EP0559706A1 (en) 1993-09-15
FI932446A7 (fi) 1993-05-28
ATE154606T1 (de) 1997-07-15
CA2096020C (en) 2003-06-17
KR100200462B1 (ko) 1999-06-15
GR3024298T3 (en) 1997-10-31
AU647226B2 (en) 1994-03-17
EP0559706A4 (enExample) 1994-02-09
NO931951L (no) 1993-05-28
NO302123B1 (no) 1998-01-26
AU9027991A (en) 1992-06-25

Similar Documents

Publication Publication Date Title
DE69116550D1 (de) Steroid-sulfatase-inhibitoren
DE3686525D1 (de) Hochfeste einkristall-superlegierungszusammensetzungen.
NO965516L (no) Sterolderivater anvendt til regulering av meiose
ES2170102T3 (es) Aminociclohexilesteres y utilizacion de los mismos.
DK550188A (da) Antigestagen- og antioestrogenvirksomme forbindelser til behandling af hormonafhaengige tumorer
ES2141559T3 (es) Derivados de 2-ciano-1-sulfonamidofenil-1,3-diona y su uso como herbicidas.
CA2003391A1 (en) Silicone hairspray compositions
DK623684A (da) Flertrinskombinationspraeparat og dets anvendelse til oral kontraception
DE59510788D1 (de) Pharmazeutische zusammensetzungen mit estra-1,3,5(10)-trien-derivaten
KR950700940A (ko) 광중합성 조성물에 사용되는 가시가능한 광 증감제(visible photosen-sitizers for photopolymerizable compositions)
CO4230020A1 (es) Derivados glicosidos esteroidales y composiciones farmaceuti cas que los contienen .
ES2168464T3 (es) Composicion acondicionadora del cabello.
ES2042556T3 (es) N,n'-diacilhidrazinas n-sustituidas, n'-sustituidas insecticidas.
FI956029L (fi) Androstaanisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät
FR2599759B1 (fr) Alliages monocristallins renforces par dispersion
NZ188755A (en) Formulations of steroids of estrane,androstane and 19-nor-pregnane series and tocol or a derivative thereof
ES2159054T3 (es) Compuestos di-terc-butil-fenolicos que contienen azufre utiles como agentes antiinflamatorios.
GB1240719A (en) New 11-halogenosteroids
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
DK605389A (da) Fremgangsmaade til fremstilling af gamma-lactoner
FI956028A7 (fi) Estreenisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neuroke miallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostum ukset ja menetelmät
ES2106800T3 (es) Composicion que contiene gamma octalactona, procedimiento de fermentacion para su produccion y usos organolepticos de la misma.
ES2103131T3 (es) Nuevos agentes de nucleosido carbociclico utiles como inhibidores selectivos de citoquinas proinflamatorias.
FI950050L (fi) (S)-timololihemihydraattia sisältävä oftalminen tooppinen koostumus
KR950702118A (ko) 5-α-환원효소 억제제로서 유용한 17-알킬케톤 스테로이드(17-Alkylketone steroids useful as 5-α-reductase inhibitors)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 559706

Country of ref document: ES